|
GIT2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.08079997676691E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.13919999997514E-06 |
| Normal-vs-Stage2 |
6.10949999999555E-05 |
| Normal-vs-Stage3 |
1.67829999999647E-05 |
| Normal-vs-Stage4 |
1.895980E-01 |
| Stage1-vs-Stage2 |
1.792640E-01 |
| Stage1-vs-Stage3 |
1.594000E-01 |
| Stage1-vs-Stage4 |
8.788000E-01 |
| Stage2-vs-Stage3 |
9.009000E-01 |
| Stage2-vs-Stage4 |
2.948000E-01 |
| Stage3-vs-Stage4 |
3.069000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.25869999873163E-08 |
| Normal-vs-AfricanAmerican |
1.48369999997122E-06 |
| Normal-vs-Asian |
8.278300E-02 |
| Caucasian-vs-AfricanAmerican |
3.836400E-01 |
| Caucasian-vs-Asian |
6.698600E-01 |
| AfricanAmerican-vs-Asian |
9.115200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.48159999824315E-08 |
| Normal-vs-Female |
7.86249999551458E-08 |
| Male-vs-Female |
5.192800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.084100E-03 |
| Normal-vs-Extreme_Weight |
6.04060000000128E-05 |
| Normal-vs-Obese |
1.35950000001994E-06 |
| Normal-vs-Extreme_Obese |
5.144200E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.576400E-01 |
| Normal_Weight-vs-Obese |
5.326400E-02 |
| Normal_Weight-vs-Extreme_Obese |
2.214400E-01 |
| Extreme_Weight-vs-Obese |
3.970500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.357810E-01 |
| Obese-vs-Extreme_Obese |
7.082500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.68510000397859E-08 |
| Normal-vs-Age(41-60Yrs) |
2.80110046269044E-10 |
| Normal-vs-Age(61-80Yrs) |
3.55779999999806E-05 |
| Normal-vs-Age(81-100Yrs) |
6.336400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.646200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.436200E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.101700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.703000E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.152000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.267600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.89030002761825E-09 |
| Normal-VS-Type2 PRCC |
8.639800E-04 |
| Normal-VS-KIRP CIMP |
3.61940000004335E-06 |
| Normal-VS-Unclassified PRCC |
1.219290E-04 |
| Type1 PRCC-VS-Type2 PRCC |
3.605600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.827600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.362200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.442230E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.573760E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.676400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.778000E-04 |
| Normal-vs-N1 |
8.11930000000904E-05 |
| Normal-vs-N2 |
1.767890E-02 |
| N0-vs-N1 |
2.515400E-01 |
| N0-vs-N2 |
9.761000E-01 |
| N1-vs-N2 |
5.280200E-01 |
|
|
